Declining Birth Rate and Increasing Population Worldwide Increases Demand for Various Human Reproductive Technologies
Decline birth rate worldwide has led to increasing adoption of various the human reproductive technologies. For instance, according to the World Bank, Japan’s birth rate, crude (per 1,000 people) decreased from 8.413 in 2005 to 7.4 in 2018. On the other hand, increasing population has also led to approval and launch of contraception products. In May 2020, Evofem Biosciences, Inc. received the U.S. Food and Drug Administration (FDA) approval for Phexxi (lactic acid, citric acid and potassium bitartrate) vaginal gel used to prevent pregnancy in females of reproductive potential for use as an on-demand method of contraception.
As the use of the human reproductive technologies advances, there is increasing concern about ethical issues surrounding these medical interventions. While the use of fertility medication has been approved by the FDA, there are still questions about how to regulate it because of the fact that it is not a prescription and because of the inherent risks associated with using the technology.
The first thing that we need to recognize is that the technology of artificial insemination has been around for decades. The only difference today is that we now have the ability to use the technology to assist in the process of getting pregnant.
Read more @ https://coherentmarketinsights-cmi.blogspot.com/2021/01/declining-birth-rate-and-increasing.html